Overview
The foramen ovale in the fetal heart allows left-to-right shunt, facilitating right atrial blood flow into the left atrium, crucial for systemic oxygenation before the closure of the ductus arteriosus and establishment of normal postnatal circulation. [Not directly addressed in provided abstracts]Diagnosis
Clinical Presentation: Often asymptomatic but can present with signs of hypoxia or polycythemia in cases of significant shunt. [Not directly addressed in provided abstracts]
Echocardiography: Primary diagnostic tool for assessing the size and patency of the foramen ovale. [Not directly addressed in provided abstracts]
Cardiac Catheterization: Rarely needed but definitive for measuring shunt magnitude. [Not directly addressed in provided abstracts]Management
Observation: Most cases require no intervention if asymptomatic and shunt is small. [Not directly addressed in provided abstracts]
Closure: Indicated for symptomatic patients or those with significant left-to-right shunting, typically postnatally using devices like the PFO occluder. [Not directly addressed in provided abstracts]Special Populations
Pregnancy: Focus on monitoring fetal well-being and managing maternal conditions that could exacerbate shunt effects. [Not directly addressed in provided abstracts]
Pediatrics: Early detection and management crucial to prevent long-term cardiovascular complications. [Not directly addressed in provided abstracts]
Elderly: Less relevant as the condition typically resolves postnatally; rare cases may require reevaluation if acquired conditions arise. [Not directly addressed in provided abstracts]
Comorbidities: Management tailored to underlying conditions; shunt may need reevaluation in presence of pulmonary hypertension or other right heart strain. [Not directly addressed in provided abstracts]Key Recommendations
Echocardiographic Monitoring: Regular echocardiographic assessment to evaluate foramen ovale size and shunt severity. (Evidence: Expert opinion [Not directly addressed in provided abstracts])
Intervention Criteria: Consider closure if symptomatic or if significant left-to-right shunt is detected postnatally. (Evidence: Expert opinion [Not directly addressed in provided abstracts])
Postnatal Follow-Up: Ensure thorough postnatal follow-up to monitor for closure naturally or need for intervention. (Evidence: Expert opinion [Not directly addressed in provided abstracts])References
1 Oak J, Gitana G, Wei S, Parry M, Tan B. Implementation of beaker CP for flow cytometry: Workflow optimization and integration at Stanford Health Care. Cytometry. Part B, Clinical cytometry 2025. link
2 Liu J, Zhang H, Lu J, Ni X, Shen Z. Quantitative model of diffuse speckle contrast analysis for flow measurement. Journal of biomedical optics 2017. link
3 Wolniak K, Goolsby C, Choi S, Ali A, Serdy N, Stetler-Stevenson M. Report of the results of the International Clinical Cytometry Society and American Society for Clinical Pathology workload survey of clinical flow cytometry laboratories. Cytometry. Part B, Clinical cytometry 2017. link
4 Wood B, Jevremovic D, Béné MC, Yan M, Jacobs P, Litwin V. Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part V - assay performance criteria. Cytometry. Part B, Clinical cytometry 2013. link
5 Davis BH, Wood B, Oldaker T, Barnett D. Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part I - rationale and aims. Cytometry. Part B, Clinical cytometry 2013. link
6 Barnett D, Louzao R, Gambell P, De J, Oldaker T, Hanson CA. Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part IV - postanalytic considerations. Cytometry. Part B, Clinical cytometry 2013. link
7 Jackson WC, Kuckuck F, Edwards BS, Mammoli A, Gallegos CM, Lopez GP et al.. Mixing small volumes for continuous high-throughput flow cytometry: performance of a mixing Y and peristaltic sample delivery. Cytometry 2002. link